LSU grad has patent pending for drug to treat COVID-19
ATLANTA- An LSU graduate and Baton Rouge native who now lives in Georgia said her company has a patent pending...
ATLANTA- An LSU graduate and Baton Rouge native who now lives in Georgia said her company has a patent pending...
Darnisha Harrison, founder and CEO of Ennaid Therapeutics, says that scientists working for her company have found a drug that is...
Ennaid was featured on the Clay Can Show on SiriusXM Urban View ch.126. You can see the full ch.126 schedule...
April 06, 2020 6:50 PM in NewsSource: WBRZBy: Chris Nakamoto ATLANTA - A Baton Rouge native and LSU grad said scientists working for her company...
ENU200 has demonstrated specific antiviral activity against two SARS-CoV-2 proteins, S glycoprotein and Mpro ALPHARETTA, Ga., April 2, 2020 /PRNewswire/ -- Ennaid Therapeutics, LLC,...
International Society of Neglected Tropical Diseases: Discovery, Development, & Diagnostics Conference (ISNTD d3) May 25-26, 2016 Darnisha Harrison Interview: ...
[vc_row row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css_animation=""][vc_column][vc_video link="https://youtu.be/bo6d6t1cr_o"][/vc_column][/vc_row]...
Researchers hope that understanding the ‘mechanism of action’ of a well-established HIV treatment could lead to the development of a...
ALPHARETTA, Ga., May 23, 2016 /PRNewswire/ -- The President and CEO of Ennaid Therapeutics, Darnisha Harrison, will be speaking at the 2016 ISNTD...